IceCure Medical Ltd. (ICCM): R&D Expense
$7.43M
Year ended 2025-12-31
-6.6%
3-year compound annual growth
+14.3%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.43M | +4.7% | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | $7.10M | -14.2% | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | $8.27M | -9.3% | 2026-03-17, From 2023-01-01 |
| 2022-12-31 | $9.12M | +55.2% | 2025-03-27, From 2022-01-01 |
| 2021-12-31 | $5.88M | +54.3% | 2024-04-03, From 2021-01-01 |
| 2020-12-31 | $3.81M | +26.9% | 2023-03-29, From 2020-01-01 |
| 2019-12-31 | $3.00M | n/a | 2022-08-22, From 2019-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| IceCure Medical Ltd. (ICCM) | 2025-12-31 | $7.43M | +4.7% |
| OSR Health, Inc. (OSRH) | 2025-12-31 | $318.4K | +97.6% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | $2.15M | -17.4% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $484.9K | +64.7% |
| Lucid Diagnostics Inc. (LUCD) | 2025-12-31 | $5.68M | -5.2% |
| Picard Medical, Inc. (PMI) | 2025-12-31 | $3.05M | -9.8% |
| Femasys Inc (FEMY) | 2025-12-31 | $7.58M | -7.8% |
| Cerenome, Inc. (CNSY) | 2025-12-31 | $8.38M | -20.8% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $10.0K | -35.0% |
Compare ICCM, OSRH, TNON, USAQ side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗